Burastero S[au] - Search Results

Year	Number of Results
1986	1
1987	1
1988	3
1989	2
1990	2
1991	2
1992	2
1993	4
1994	3
1995	2
1996	6
1997	6
1998	1
1999	7
2000	3
2001	1
2003	4
2004	5
2005	6
2006	12
2007	2
2008	4
2009	6
2010	2
2011	4
2012	2
2014	2
2015	1
2016	4
2017	3
2018	1
2020	2
2021	1
2022	1

1

The allergen Mus m 1.0102: Cysteine residues and molecular allergology.

Ferrari E, Corsini R, Burastero SE, Tanfani F, Spisni A. Ferrari E, et al. Among authors: burastero se. Mol Immunol. 2020 Apr;120:1-12. doi: 10.1016/j.molimm.2020.01.022. Epub 2020 Feb 7. Mol Immunol. 2020. PMID: 32044430 Free article.

2

Heterogeneity in exposed uninfected individuals.

Lopalco L, Pastori C, Barassi C, Furci L, Burastero S, Lillo F, Boeri E, Soldini L, Tambussi G, Lazzarin A, Beretta A, Siccardi AG. Lopalco L, et al. Among authors: burastero s. J Biol Regul Homeost Agents. 1997 Jan-Jun;11(1-2):27-31. J Biol Regul Homeost Agents. 1997. PMID: 9418157 Review.

3

IgE reactivity to house dust mite allergen components in sensitized asymptomatic subjects: a role for Der p 20.

Conti A, Burastero GJ, Hales BJ, Breda D, Alessio M, Burastero SE. Conti A, et al. Among authors: burastero se. J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2):669-676. doi: 10.23812/21-07-L. J Biol Regul Homeost Agents. 2021. PMID: 33851528 No abstract available.

4

T-cell receptor-mediated cross-allergenicity.

Burastero SE, Paolucci C, Breda D, Longhi R, Silvestri M, Hammer J, Protti MP, Rossi GA. Burastero SE, et al. Int Arch Allergy Immunol. 2004 Dec;135(4):296-305. doi: 10.1159/000082323. Epub 2004 Nov 24. Int Arch Allergy Immunol. 2004. PMID: 15583456

5

Risk factors for musculoskeletal disorders among computer users.

Tittiranonda P, Burastero S, Rempel D. Tittiranonda P, et al. Among authors: burastero s. Occup Med. 1999 Jan-Mar;14(1):17-38, iii. Occup Med. 1999. PMID: 9950008 Review.

6

Pollen-cross allergenicity mediated by panallergens: a clue to the patho-genesis of multiple sensitizations.

Burastero SE. Burastero SE. Inflamm Allergy Drug Targets. 2006 Dec;5(4):203-9. doi: 10.2174/187152806779010918. Inflamm Allergy Drug Targets. 2006. PMID: 17168790 Review.

7

Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection.

Burastero SE, Figini M, Frigerio B, Lusso P, Mollica L, Lopalco L. Burastero SE, et al. J Transl Med. 2009 Nov 28;7:101. doi: 10.1186/1479-5876-7-101. J Transl Med. 2009. PMID: 19943950 Free PMC article. Review.

8

Thermal stability, ligand binding and allergenicity data of Mus m 1.0102 allergen and its cysteine mutants.

Ferrari E, Corsini R, Burastero SE, Tanfani F, Spisni A. Ferrari E, et al. Among authors: burastero se. Data Brief. 2020 Feb 29;29:105355. doi: 10.1016/j.dib.2020.105355. eCollection 2020 Apr. Data Brief. 2020. PMID: 32190721 Free PMC article.

9

Serum diamine oxidase activity in patients with histamine intolerance.

Manzotti G, Breda D, Di Gioacchino M, Burastero SE. Manzotti G, et al. Among authors: burastero se. Int J Immunopathol Pharmacol. 2016 Mar;29(1):105-11. doi: 10.1177/0394632015617170. Epub 2015 Nov 16. Int J Immunopathol Pharmacol. 2016. PMID: 26574488 Free PMC article.

10

Ambient pollutants as adjuvant for allergic sensitization: the emerging role of platinum group elements.

Burastero SE, Paolucci C, Fabbri M. Burastero SE, et al. J Biol Regul Homeost Agents. 2009 Oct-Dec;23(4):207-15. J Biol Regul Homeost Agents. 2009. PMID: 20003759 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results